Journal
INTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume 379, Issue 2, Pages 285-292Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ijpharm.2009.04.035
Keywords
PLGA; Nanoparticles; blood-brain barrier; Transferrin; Caveolae
Categories
Funding
- French Research Ministry
Ask authors/readers for more resources
Many studies showed that transferrin increases brain delivery of nanoparticles (NPs) in vivo, however the mechanisms implied in their brain uptake are not yet clearly elucidated. In this study we evaluated the endocytosis of PLGA NPs coated with transferrin on an in vitro model of the blood-brain barrier (BBB) made of a co-culture of brain endothelial cells and astrocytes. PLGA NPs were prepared using Dil as a fluorescent marker and coated with Tween (R) 20, BSA and transferrin (Tf). Blank and BSA-NPs served as controls. The cellular toxicity on BBB of the different samples was evaluated following tight junction aperture and due to high toxicity NPs prepared with Tween (R) 20 were discarded. The size of the NPs prepared by the solvent diffusion method, varied from 63 to 90 nm depending on Dil incorporation and surface coating. Proteins adsorption on the surface of the NPs was found to be stable for at least 12 days at 37 degrees C. Contrary to Blank or BSA-NPs, Tf-NPs were found to be highly adsorbed by the cells and endocytosed using an energy-dependent process. Studies in presence of inhibitors suggest that Tf-NPs interact with the cells in a specific manner and enter the cells via the caveolae pathway. (C) 2009 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available